Medical policy: Foot Care Services
Policy number: MP 4.018
Clinical benefit
- Minimize safety risk or concern.
- Minimize harmful or ineffective interventions.
- Assure appropriate level of care.
- Assure appropriate duration of service for interventions.
- Assure that recommended medical prerequisites have been met.
- Assure appropriate site of treatment or service.
Effective date: 10/1/2026
Policy
Routine foot care services may be considered medically necessary when there is:
- Systemic disease (metabolic, neurologic, or peripheral vascular) that would put the patient at risk if provided by a nonprofessional person. Conditions that may result in the need for routine foot care include the following:
- Amyotrophic Lateral Sclerosis (ALS)
- Arteriosclerosis obliterans (A.S.O.), arteriosclerosis of the extremities, occlusive peripheral arteriosclerosis
- Arteritis of the feet
- Buerger’s disease
- Chronic indurated cellulitis
- Chronic venous insufficiency
- Diabetes mellitus
- Intractable edema
- Lymphedema (moderate to severe; based on any grading system i.e., The National Cancer Institute Common Terminology for Adverse Events (CTCAE), The American Physical Therapy Association (APTA) or The International Society of Lymphology (ISL))
- Peripheral neuropathies involving the feet (associated with, but not limited to, the following):
- Associated with malnutrition and vitamin deficiency
- Malnutrition (general, pellagra)
- Alcoholism
- Malabsorption (celiac disease, tropical sprue)
- Pernicious anemia
- Associated with carcinoma
- Associated with diabetes mellitus
- Associated with drugs and toxins (including, but not limited to, anticoagulants and immune modulating medications)
- Associated with multiple sclerosis
- Associated with uremia (chronic kidney disease [CKD])
- Associated with traumatic injury
- Associated with leprosy or neurosyphilis
- Associated with hereditary disorders (including, but not limited to, the following):
- Hereditary sensory radicular neuropathy
- Angiokeratoma corporis diffusum (Fabry’s)
- Amyloid neuropathy
- Associated with Rheumatoid arthritis
- Associated with malnutrition and vitamin deficiency
- Peripheral vascular disease
- Raynaud’s phenomenon secondary to a concurrent connective tissue disease
- Stricture of artery
Evaluation and debridement of mycotic nails may be considered medically necessary when the above criteria are met.
Evaluation and debridement of mycotic nails, in the absence of a systemic condition listed above, may be considered medically necessary when the following criteria are met.
- The patient is diagnosed as having tinea unguium (onychomycoses or dermatophytoses)
- Pain and/or secondary infection resulting from the thickening and dystrophy of the infected toenail plate
- If ambulatory, marked limitation of ambulation (pain and/or abnormality of gait)
Product variations
This policy is only applicable to certain programs and products administered by Capital Blue Cross and subject to benefit variations. Please see additional information below.
FEP PPO - Refer to the FEP Medical Policy Manual. The FEP Medical Policy Manual can be found at: FEP Medical Policy Manual.
Description/Background
Foot care services include the examination, diagnosis and medical or surgical treatment of conditions and dysfunctions of the foot. Foot care services can be routine or non-routine. In most cases, routine foot care does not require the skills of a qualified provider of foot care services, i.e., a podiatrist or physician. However, there are clinical diagnoses such as poor circulation to the extremities and other conditions where the services of a professional foot care provider may be medically necessary in order to limit complications such as delayed healing or infection.
Rationale
N/A
Definitions
Mycotic refers to being caused by or infected with fungus.
Non-routine foot care would include surgical treatment of structural defects or anomalies such as fractures, hammer toes, or bunions. It also includes surgery for ingrown toenails. An injectable local anesthetic must be used in order for a foot procedure to be considered "toenail surgery."
Keratoma (also known as a callus) are hard, light-colored patches of skin that develop as a result of friction or pressure.
Tyloma is a localized overgrowth of skin due to pressure or friction.
Routine foot care involves, but is not limited to, hygiene and maintenance care (e.g., cleaning and soaking of feet, use of skin creams to maintain skin tone), trimming of nails (except surgery for ingrown nails), treatment of corns, calluses, keratoses, nonsurgical treatment of bunions, and treatment and debridement of mycotic nails.
Disclaimer
Capital Blue Cross’ medical policies are used to determine coverage for specific medical technologies, procedures, equipment, and services. These medical policies do not constitute medical advice and are subject to change as permitted by law or applicable clinical evidence from independent treatment guidelines. Treating providers are solely responsible for medical advice and treatment of members. These policies are not a guarantee of coverage or payment. Payment of claims is subject to a determination regarding the member’s benefit program and eligibility on the date of service, and a determination that the services are medically necessary and appropriate. Final processing of a claim is based upon the terms of contract that applies to the members’ benefit program, including benefit limitations and exclusions. If a provider or a member has a question concerning this medical policy, please contact Capital Blue Cross’ Provider Services or Member Services.
Coding information
Note: This list of codes may not be all-inclusive, and codes are subject to change at any time. The identification of a code in this section does not denote coverage as coverage is determined by the terms of member benefit information. In addition, not all covered services are eligible for separate reimbursement.
Covered when medically necessary
Procedure codes |
||||
|
11055 |
11056 |
11057 |
11719 |
11720 |
|
11721 |
G0127 |
G0247 |
S0390 |
|
ICD-10-CM diagnosis codes |
Description |
|
A30.0 |
Indeterminate leprosy |
|
A30.1 |
Tuberculoid leprosy |
|
A30.2 |
Borderline tuberculoid leprosy |
|
A30.3 |
Borderline leprosy |
|
A30.4 |
Borderline lepromatous leprosy |
|
A30.5 |
Lepromatous leprosy |
|
A30.8 |
Other forms of leprosy |
|
A30.9 |
Leprosy, unspecified |
|
A50.40 |
Late congenital neurosyphilis, unspecified |
|
A50.43 |
Late congenital syphilitic polyneuropathy |
|
A50.45 |
Juvenile general paresis |
|
A52.15 |
Late syphilitic neuropathy |
|
A52.16 |
Charcot's arthropathy (tabetic) |
|
A52.17 |
General paresis |
|
A52.19 |
Other symptomatic neurosyphilis |
|
A52.2 |
Asymptomatic neurosyphilis |
|
D09.8 |
Carcinoma in situ of other specified sites |
|
D09.9 |
Carcinoma in situ, unspecified |
|
D51.0 |
Vitamin B12 deficiency anemia due to intrinsic factor deficiency |
|
E08.00 |
Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC) |
|
E08.10 |
Diabetes mellitus due to underlying condition with ketoacidosis without coma |
|
E08.21 |
Diabetes mellitus due to underlying condition with diabetic nephropathy |
|
E08.22 |
Diabetes mellitus due to underlying condition with diabetic chronic kidney disease |
|
E08.29 |
Diabetes mellitus due to underlying condition with other diabetic kidney complication |
|
E08.40 |
Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified |
|
E08.41 |
Diabetes mellitus due to underlying condition with diabetic mononeuropathy |
|
E08.42 |
Diabetes mellitus due to underlying condition with diabetic polyneuropathy |
|
E08.43 |
Diabetes mellitus due to underlying condition with diabetic autonomic (poly)neuropathy |
|
E08.44 |
Diabetes mellitus due to underlying condition with diabetic amyotrophy |
|
E08.49 |
Diabetes mellitus due to underlying condition with other diabetic neurological complication |
|
E08.51 |
Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy without gangrene |
|
E08.52 |
Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy with gangrene |
|
E08.59 |
Diabetes mellitus due to underlying condition with other circulatory complications |
|
E08.610 |
Diabetes mellitus due to underlying condition with diabetic neuropathic arthropathy |
|
E08.618 |
Diabetes mellitus due to underlying condition with other diabetic arthropathy |
|
E08.620 |
Diabetes mellitus due to underlying condition with diabetic dermatitis |
|
E08.621 |
Diabetes mellitus due to underlying condition with foot ulcer |
|
E08.622 |
Diabetes mellitus due to underlying condition with other skin ulcer |
|
E08.628 |
Diabetes mellitus due to underlying condition with other skin complications |
|
E08.65 |
Diabetes mellitus due to underlying condition with hyperglycemia |
|
E08.69 |
Diabetes mellitus due to underlying condition with other specified complication |
|
E08.8 |
Diabetes mellitus due to underlying condition with unspecified complications |
|
E08.9 |
Diabetes mellitus due to underlying condition without complications |
|
E09.00 |
Drug or chemical induced diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC) |
|
E09.10 |
Drug or chemical induced diabetes mellitus with ketoacidosis without coma |
|
E09.21 |
Drug or chemical induced diabetes mellitus with diabetic nephropathy |
|
E09.22 |
Drug or chemical induced diabetes mellitus with diabetic chronic kidney disease |
|
E09.29 |
Drug or chemical induced diabetes mellitus with other diabetic kidney complication |
|
E09.40 |
Drug or chemical induced diabetes mellitus with neurological complications with diabetic neuropathy, unspecified |
|
E09.41 |
Drug or chemical induced diabetes mellitus with neurological complications with diabetic mononeuropathy |
|
E09.42 |
Drug or chemical induced diabetes mellitus with neurological complications with diabetic polyneuropathy |
|
E09.43 |
Drug or chemical induced diabetes mellitus with neurological complications with diabetic autonomic (poly)neuropathy |
|
E09.44 |
Drug or chemical induced diabetes mellitus with neurological complications with diabetic amyotrophy |
|
E09.49 |
Drug or chemical induced diabetes mellitus with neurological complications with other diabetic neurological complication |
|
E09.51 |
Drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy without gangrene |
|
E09.52 |
Drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy with gangrene |
|
E09.59 |
Drug or chemical induced diabetes mellitus with other circulatory complications |
|
E09.610 |
Drug or chemical induced diabetes mellitus with diabetic neuropathic arthropathy |
|
E09.618 |
Drug or chemical induced diabetes mellitus with other diabetic arthropathy |
|
E09.620 |
Drug or chemical induced diabetes mellitus with diabetic dermatitis |
|
E09.621 |
Drug or chemical induced diabetes mellitus with foot ulcer |
|
E09.622 |
Drug or chemical induced diabetes mellitus with other skin ulcer |
|
E09.628 |
Drug or chemical induced diabetes mellitus with other skin complications |
|
E09.649 |
Drug or chemical induced diabetes mellitus with hypoglycemia without coma |
|
E09.65 |
Drug or chemical induced diabetes mellitus with hyperglycemia |
|
E09.69 |
Drug or chemical induced diabetes mellitus with other specified complication |
|
E09.8 |
Drug or chemical induced diabetes mellitus with unspecified complications |
|
E09.9 |
Drug or chemical induced diabetes mellitus without complications |
|
E10.A0 |
Type 1 diabetes mellitus, presymptomatic, unspecified |
|
E10.A1 |
Type 1 diabetes mellitus, presymptomatic, Stage 1 |
|
E10.A2 |
Type 1 diabetes mellitus, presymptomatic, Stage 2 |
|
E10.10 |
Type 1 diabetes mellitus with ketoacidosis without coma |
|
E10.21 |
Type 1 diabetes mellitus with diabetic nephropathy |
|
E10.22 |
Type 1 diabetes mellitus with diabetic chronic kidney disease |
|
E10.29 |
Type 1 diabetes mellitus with other diabetic kidney complication |
|
E10.40 |
Type 1 diabetes mellitus with diabetic neuropathy, unspecified |
|
E10.41 |
Type 1 diabetes mellitus with diabetic mononeuropathy |
|
E10.42 |
Type 1 diabetes mellitus with diabetic polyneuropathy |
|
E10.43 |
Type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy |
|
E10.44 |
Type 1 diabetes mellitus with diabetic amyotrophy |
|
E10.49 |
Type 1 diabetes mellitus with other diabetic neurological complication |
|
E10.51 |
Type 1 diabetes mellitus with diabetic peripheral angiopathy without gangrene |
|
E10.52 |
Type 1 diabetes mellitus with diabetic peripheral angiopathy with gangrene |
|
E10.59 |
Type 1 diabetes mellitus with other circulatory complications |
|
E10.610 |
Type 1 diabetes mellitus with diabetic neuropathic arthropathy |
|
E10.618 |
Type 1 diabetes mellitus with other diabetic arthropathy |
|
E10.620 |
Type 1 diabetes mellitus with diabetic dermatitis |
|
E10.621 |
Type 1 diabetes mellitus with foot ulcer |
|
E10.622 |
Type 1 diabetes mellitus with other skin ulcer |
|
E10.628 |
Type 1 diabetes mellitus with other skin complications |
|
E10.649 |
Type 1 diabetes mellitus with hypoglycemia without coma |
|
E10.65 |
Type 1 diabetes mellitus with hyperglycemia |
|
E10.69 |
Type 1 diabetes mellitus with other specified complication |
|
E10.8 |
Type 1 diabetes mellitus with unspecified complications |
|
E10.9 |
Type 1 diabetes mellitus without complications |
|
E11.00 |
Type 2 diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC) |
|
E11.10 |
Type 2 diabetes mellitus with ketoacidosis without coma |
|
E11.21 |
Type 2 diabetes mellitus with diabetic nephropathy |
|
E11.22 |
Type 2 diabetes mellitus with diabetic chronic kidney disease |
|
E11.29 |
Type 2 diabetes mellitus with other diabetic kidney complication |
|
E11.40 |
Type 2 diabetes mellitus with diabetic neuropathy, unspecified |
|
E11.41 |
Type 2 diabetes mellitus with diabetic mononeuropathy |
|
E11.42 |
Type 2 diabetes mellitus with diabetic polyneuropathy |
|
E11.43 |
Type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy |
|
E11.44 |
Type 2 diabetes mellitus with diabetic amyotrophy |
|
E11.49 |
Type 2 diabetes mellitus with other diabetic neurological complication |
|
E11.51 |
Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene |
|
E11.52 |
Type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene |
|
E11.59 |
Type 2 diabetes mellitus with other circulatory complications |
|
E11.610 |
Type 2 diabetes mellitus with diabetic neuropathic arthropathy |
|
E11.618 |
Type 2 diabetes mellitus with other diabetic arthropathy |
|
E11.620 |
Type 2 diabetes mellitus with diabetic dermatitis |
|
E11.621 |
Type 2 diabetes mellitus with foot ulcer |
|
E11.622 |
Type 2 diabetes mellitus with other skin ulcer |
|
E11.628 |
Type 2 diabetes mellitus with other skin complications |
|
E11.649 |
Type 2 diabetes mellitus with hypoglycemia without coma |
|
E11.65 |
Type 2 diabetes mellitus with hyperglycemia |
|
E11.69 |
Type 2 diabetes mellitus with other specified complication |
|
E11.8 |
Type 2 diabetes mellitus with unspecified complications |
|
E11.9 |
Type 2 diabetes mellitus without complications |
|
E11.A |
Type 2 diabetes mellitus without complications in remission |
|
E13.00 |
Other specified diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC) |
|
E13.10 |
Other specified diabetes mellitus with ketoacidosis without coma |
|
E13.21 |
Other specified diabetes mellitus with diabetic nephropathy |
|
E13.22 |
Other specified diabetes mellitus with diabetic chronic kidney disease |
|
E13.29 |
Other specified diabetes mellitus with other diabetic kidney complication |
|
E13.40 |
Other specified diabetes mellitus with diabetic neuropathy, unspecified |
|
E13.41 |
Other specified diabetes mellitus with diabetic mononeuropathy |
|
E13.42 |
Other specified diabetes mellitus with diabetic polyneuropathy |
|
E13.43 |
Other specified diabetes mellitus with diabetic autonomic (poly)neuropathy |
|
E13.44 |
Other specified diabetes mellitus with diabetic amyotrophy |
|
E13.49 |
Other specified diabetes mellitus with other diabetic neurological complication |
|
E13.51 |
Other specified diabetes mellitus with diabetic peripheral angiopathy without gangrene |
|
E13.52 |
Other specified diabetes mellitus with diabetic peripheral angiopathy with gangrene |
|
E13.59 |
Other specified diabetes mellitus with other circulatory complications |
|
E13.610 |
Other specified diabetes mellitus with diabetic neuropathic arthropathy |
|
E13.618 |
Other specified diabetes mellitus with other diabetic arthropathy |
|
E13.620 |
Other specified diabetes mellitus with diabetic dermatitis |
|
E13.621 |
Other specified diabetes mellitus with foot ulcer |
|
E13.622 |
Other specified diabetes mellitus with other skin ulcer |
|
E13.628 |
Other specified diabetes mellitus with other skin complications |
|
E13.649 |
Other specified diabetes mellitus with hypoglycemia without coma |
|
E13.65 |
Other specified diabetes mellitus with hyperglycemia |
|
E13.69 |
Other specified diabetes mellitus with other specified complication |
|
E13.8 |
Other specified diabetes mellitus with unspecified complications |
|
E13.9 |
Other specified diabetes mellitus without complications |
|
E52 |
Niacin deficiency [pellagra] |
|
E53.0 |
Riboflavin deficiency |
|
E53.1 |
Pyridoxine deficiency |
|
E53.8 |
Deficiency of other specified B group vitamins |
|
E75.21 |
Fabry (-Anderson) disease |
|
E85.1 |
Neuropathic heredofamilial amyloidosis |
|
G12.21 |
Amyotrophic lateral sclerosis |
|
G13.0 |
Paraneoplastic neuromyopathy and neuropathy |
|
G35 |
Multiple sclerosis |
|
G35.A |
Relapsing-remitting multiple sclerosis |
|
G35.B |
Primary progressive multiple sclerosis |
|
G35.B0 |
Primary progressive multiple sclerosis, unspecified |
|
G35.B1 |
Active primary progressive multiple sclerosis |
|
G35.B2 |
Non-active primary progressive multiple sclerosis |
|
G35.C |
Secondary progressive multiple sclerosis |
|
G35.C0 |
Secondary progressive multiple sclerosis, unspecified |
|
G35.C1 |
Active secondary progressive multiple sclerosis |
|
G35.C2 |
Non-active secondary progressive multiple sclerosis |
|
G35.D |
Multiple sclerosis, unspecified |
|
G60.0 |
Hereditary motor and sensory neuropathy |
|
G60.2 |
Neuropathy in association with hereditary ataxia |
|
G60.3 |
Idiopathic progressive neuropathy |
|
G60.8 |
Other hereditary and idiopathic neuropathies |
|
G60.9 |
Hereditary and idiopathic neuropathy, unspecified |
|
G61.0 |
Guillain-Barre syndrome |
|
G61.1 |
Serum neuropathy |
|
G61.81 |
Chronic inflammatory demyelinating polyneuritis |
|
G61.89 |
Other inflammatory polyneuropathies |
|
G62.0 |
Drug-induced polyneuropathy |
|
G62.1 |
Alcoholic polyneuropathy |
|
G62.2 |
Polyneuropathy due to other toxic agents |
|
G62.81 |
Critical illness polyneuropathy |
|
G62.82 |
Radiation-induced polyneuropathy |
|
G62.89 |
Other specified polyneuropathies |
|
G62.9 |
Polyneuropathy, unspecified |
|
G63 |
Polyneuropathy in diseases classified elsewhere |
|
G64 |
Other disorders of peripheral nervous system |
|
G65.0 |
Sequelae of Guillain-Barre syndrome |
|
G65.1 |
Sequelae of other inflammatory polyneuropathy |
|
G65.2 |
Sequelae of toxic polyneuropathy |
|
G90.09 |
Other idiopathic peripheral autonomic neuropathy |
|
G99.0 |
Autonomic neuropathy in diseases classified elsewhere |
|
I70.201 |
Unspecified atherosclerosis of native arteries of extremities, right leg |
|
I70.202 |
Unspecified atherosclerosis of native arteries of extremities, left leg |
|
I70.203 |
Unspecified atherosclerosis of native arteries of extremities, bilateral legs |
|
I70.208 |
Unspecified atherosclerosis of native arteries of extremities, other extremity |
|
I70.209 |
Unspecified atherosclerosis of native arteries of extremities, unspecified extremity |
|
I70.211 |
Atherosclerosis of native arteries of extremities with intermittent claudication, right leg |
|
I70.212 |
Atherosclerosis of native arteries of extremities with intermittent claudication, left leg |
|
I70.213 |
Atherosclerosis of native arteries of extremities with intermittent claudication, bilateral legs |
|
I70.218 |
Atherosclerosis of native arteries of extremities with intermittent claudication, other extremity |
|
I70.219 |
Atherosclerosis of native arteries of extremities with intermittent claudication, unspecified extremity |
|
I70.221 |
Atherosclerosis of native arteries of extremities with rest pain, right leg |
|
I70.222 |
Atherosclerosis of native arteries of extremities with rest pain, left leg |
|
I70.223 |
Atherosclerosis of native arteries of extremities with rest pain, bilateral legs |
|
I70.228 |
Atherosclerosis of native arteries of extremities with rest pain, other extremity |
|
I70.229 |
Atherosclerosis of native arteries of extremities with rest pain, unspecified extremity |
|
I70.231 |
Atherosclerosis of native arteries of right leg with ulceration of thigh |
|
I70.232 |
Atherosclerosis of native arteries of right leg with ulceration of calf |
|
I70.233 |
Atherosclerosis of native arteries of right leg with ulceration of ankle |
|
I70.234 |
Atherosclerosis of native arteries of right leg with ulceration of heel and midfoot |
|
I70.235 |
Atherosclerosis of native arteries of right leg with ulceration of other part of foot |
|
I70.238 |
Atherosclerosis of native arteries of right leg with ulceration of other part of lower right leg |
|
I70.239 |
Atherosclerosis of native arteries of right leg with ulceration of unspecified site |
|
I70.241 |
Atherosclerosis of native arteries of left leg with ulceration of thigh |
|
I70.242 |
Atherosclerosis of native arteries of left leg with ulceration of calf |
|
I70.243 |
Atherosclerosis of native arteries of left leg with ulceration of ankle |
|
I70.244 |
Atherosclerosis of native arteries of left leg with ulceration of heel and midfoot |
|
I70.245 |
Atherosclerosis of native arteries of left leg with ulceration of other part of foot |
|
I70.248 |
Atherosclerosis of native arteries of left leg with ulceration of other part of lower left leg |
|
I70.249 |
Atherosclerosis of native arteries of left leg with ulceration of unspecified site |
|
I70.261 |
Atherosclerosis of native arteries of extremities with gangrene, right leg |
|
I70.262 |
Atherosclerosis of native arteries of extremities with gangrene, left leg |
|
I70.263 |
Atherosclerosis of native arteries of extremities with gangrene, bilateral legs |
|
I70.269 |
Atherosclerosis of native arteries of extremities with gangrene, unspecified extremity |
|
I70.291 |
Other atherosclerosis of native arteries of extremities, right leg |
|
I70.292 |
Other atherosclerosis of native arteries of extremities, left leg |
|
I70.293 |
Other atherosclerosis of native arteries of extremities, bilateral legs |
|
I70.299 |
Other atherosclerosis of native arteries of extremities, unspecified extremity |
|
I70.90 |
Unspecified atherosclerosis |
|
I70.91 |
Generalized atherosclerosis |
|
I73.00 |
Raynaud's syndrome without gangrene |
|
I73.01 |
Raynaud's syndrome with gangrene |
|
I73.1 |
Thromboangiitis obliterans [Buerger's disease] |
|
I73.81 |
Erythromelalgia |
|
I73.89 |
Other specified peripheral vascular diseases |
|
I73.9 |
Peripheral vascular disease, unspecified |
|
I77.1 |
Stricture of artery |
|
I77.6 |
Arteritis, unspecified |
|
I79.1 |
Aortitis in diseases classified elsewhere |
|
I79.8 |
Other disorders of arteries, arterioles and capillaries in diseases classified elsewhere |
|
I87.1 |
Compression of vein |
|
I87.2 |
Venous insufficiency (chronic) (peripheral) |
|
I87.301 |
Chronic venous hypertension (idiopathic) without complications of right lower extremity |
|
I87.302 |
Chronic venous hypertension (idiopathic) without complications of left lower extremity |
|
I87.303 |
Chronic venous hypertension (idiopathic) without complications of bilateral lower extremity |
|
I87.311 |
Chronic venous hypertension (idiopathic) with ulcer of right lower extremity |
|
I87.312 |
Chronic venous hypertension (idiopathic) with ulcer of left lower extremity |
|
I87.313 |
Chronic venous hypertension (idiopathic) with ulcer of bilateral lower extremity |
|
I87.321 |
Chronic venous hypertension (idiopathic) with inflammation of right lower extremity |
|
I87.322 |
Chronic venous hypertension (idiopathic) with inflammation of left lower extremity |
|
I87.323 |
Chronic venous hypertension (idiopathic) with inflammation of bilateral lower extremity |
|
I87.329 |
Chronic venous hypertension (idiopathic) with inflammation of unspecified lower extremity |
|
I87.331 |
Chronic venous hypertension (idiopathic) with ulcer and inflammation of right lower extremity |
|
I87.332 |
Chronic venous hypertension (idiopathic) with ulcer and inflammation of left lower extremity |
|
I87.333 |
Chronic venous hypertension (idiopathic) with ulcer and inflammation of bilateral lower extremity |
|
I87.339 |
Chronic venous hypertension (idiopathic) with ulcer and inflammation of unspecified lower extremity |
|
I87.391 |
Chronic venous hypertension (idiopathic) with other complications of right lower extremity |
|
I87.392 |
Chronic venous hypertension (idiopathic) with other complications of left lower extremity |
|
I87.393 |
Chronic venous hypertension (idiopathic) with other complications of bilateral lower extremity |
|
I87.399 |
Chronic venous hypertension (idiopathic) with other complications of unspecified lower extremity |
|
I87.8 |
Other specified disorders of veins |
|
I89.0 |
Lymphedema, not elsewhere classified |
|
I99.8 |
Other disorder of circulatory system |
|
K90.0 |
Celiac disease |
|
K90.1 |
Tropical sprue |
|
K90.9 |
Intestinal malabsorption, unspecified |
|
L02.415 |
Cutaneous abscess of right lower limb |
|
L02.416 |
Cutaneous abscess of left lower limb |
|
L02.611 |
Cutaneous abscess of right foot |
|
L02.612 |
Cutaneous abscess of left foot |
|
L02.619 |
Cutaneous abscess of unspecified foot |
|
L03.031 |
Cellulitis of right toe |
|
L03.032 |
Cellulitis of left toe |
|
L03.039 |
Cellulitis of unspecified toe |
|
L03.115 |
Cellulitis of right lower limb |
|
L03.116 |
Cellulitis of left lower limb |
|
L03.125 |
Acute lymphangitis of right lower limb |
|
L03.126 |
Acute lymphangitis of left lower limb |
|
L03.41 |
Acute lymphangitis of right toe |
|
L03.42 |
Acute lymphangitis of left toe |
|
L98.3 |
Eosinophilic cellulitis [Wells] |
|
M05.50 |
Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified site |
|
M05.511 |
Rheumatoid polyneuropathy with rheumatoid arthritis of right shoulder |
|
M05.512 |
Rheumatoid polyneuropathy with rheumatoid arthritis of left shoulder |
|
M05.519 |
Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified shoulder |
|
M05.521 |
Rheumatoid polyneuropathy with rheumatoid arthritis of right elbow |
|
M05.522 |
Rheumatoid polyneuropathy with rheumatoid arthritis of left elbow |
|
M05.529 |
Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified elbow |
|
M05.531 |
Rheumatoid polyneuropathy with rheumatoid arthritis of right wrist |
|
M05.532 |
Rheumatoid polyneuropathy with rheumatoid arthritis of left wrist |
|
M05.539 |
Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified wrist |
|
M05.541 |
Rheumatoid polyneuropathy with rheumatoid arthritis of right hand |
|
M05.542 |
Rheumatoid polyneuropathy with rheumatoid arthritis of left hand |
|
M05.549 |
Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified hand |
|
M05.551 |
Rheumatoid polyneuropathy with rheumatoid arthritis of right hip |
|
M05.552 |
Rheumatoid polyneuropathy with rheumatoid arthritis of left hip |
|
M05.559 |
Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified hip |
|
M05.561 |
Rheumatoid polyneuropathy with rheumatoid arthritis of right knee |
|
M05.562 |
Rheumatoid polyneuropathy with rheumatoid arthritis of left knee |
|
M05.569 |
Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified knee |
|
M05.571 |
Rheumatoid polyneuropathy with rheumatoid arthritis of right ankle and foot |
|
M05.572 |
Rheumatoid polyneuropathy with rheumatoid arthritis of left ankle and foot |
|
M05.579 |
Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified ankle and foot |
|
M05.59 |
Rheumatoid polyneuropathy with rheumatoid arthritis of multiple sites |
|
M34.83 |
Systemic sclerosis with polyneuropathy |
|
N18.1 |
Chronic kidney disease, stage 1 |
|
N18.2 |
Chronic kidney disease, stage 2 (mild) |
|
N18.30 |
Chronic kidney disease, stage 3 unspecified |
|
N18.31 |
Chronic kidney disease, stage 3a |
|
N18.32 |
Chronic kidney disease, stage 3b |
|
N18.4 |
Chronic kidney disease, stage 4 (severe) |
|
N18.5 |
Chronic kidney disease, stage 5 |
|
N18.6 |
End stage renal disease |
|
N18.9 |
Chronic kidney disease, unspecified |
|
Q82.0 |
Hereditary lymphedema |
|
R23.4 |
Changes in skin texture (Induration of skin; scaling of skin) |
|
R60.0 |
Localized edema |
|
R60.1 |
Generalized edema |
|
R60.9 |
Edema, unspecified |
|
Z86.31 |
Personal history of diabetic foot ulcer |
|
Z86.79 |
Personal history of other diseases of the circulatory system |
Covered when medically necessary
Procedure codes |
||||
|
11720 |
11721 |
G0127 |
G0247 |
S0390 |
ICD-10-CM diagnosis codes |
Description |
|
B35.1 |
Tinea unguium |
References
- Services National Coverage Determination (NCD), 70.2.1. Services provided for the Diagnosis and Treatment of Diabetic Sensory Neuropathy with Loss of Protective Sensation (aka Diabetic Peripheral Neuropathy). Effective 7/1/2002. CMS.
- Taber’s Cyclopedic Medical Dictionary, 19th edition.
- PA State Board of Podiatry Act. P.L. 1199, No. 505.
- Bending A. Fungal nail infections: Far more than an aesthetic problem. Br J Community Nurs. 2002; 7(5):254-259. PMID: 12048499.
- Schaper NC, van Netten JJ, et al. Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev. 2020; 36(S1):e3266.
- Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes−2020 (ADA). Diabetes Care. January 2020; 43(Supplement 1): S135-S151.
- Wexler DJ. Foot evaluation in people with diabetes mellitus. In: UpToDate Online Journal [serial online]. Waltham, MA: UpToDate; updated Dec. 19, 2025. Literature review current through April 2026.
- Local Coverage Determination (LCD), L35138. Routine Foot Care. Effective 10/17/2019. CMS.
- Medicare Benefit Policy Manual. Chapter 15-Covered Medical and Other Health Services. Issued: 05/08/2026, Rev. 13774. CMS.
- Lacouture ME, Kopsky DJ, Lilker R, et al. Podiatric Adverse Events and Foot Care in Cancer Patients and Survivors Awareness, Education, and Literature Review. J Am Podiatr Med Assoc. 2018;108(6):508-516. PMID: 30742505.
- Senneville É, Albalawi Z, van Asten SA, et al. IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023). Diabetes Metab Res Rev. 2024;40(3):e3687. PMID: 37779323.
- American Diabetes Association; Professional Practice Committee. Standards of Medical Care in Diabetes—2026. Diabetes Care. 1 January 2026; 49(Supplement_1).
- Pop-Busui R, Boulton AJM, et al. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care. 1 January 2017; 40(1):136-154.
Policy history |
|
|
MP 2.018 |
09/21/2022 Consensus review. Coding reviewed. ICD codes updated (added A30.9, A52.19, E09.8, I87.329, I87.339, I87.399, N18.30, N18.31, N18.32). References updated. |
|
05/30/2023 Consensus review. References updated. Coding reviewed. Deleted S99.821A and S99.822A. Added E11.10 and E11.649. |
|
|
06/14/2024 Consensus review. No change to policy stance. New references. |
|
|
05/07/2025 Consensus review. No change to policy stance. Added ICD-10 codes E10.A0-E10.A2. |
|
|
09/02/2025 Administrative update. New ICD codes added effective 10/01/2025. |
|
|
05/29/2026 Consensus review. No change to policy stance. References and ICD-10 table updated. Added ICD-10 code G62.82. Clarification: ICD-10 code B35.1 is for procedure codes 11720, 11721, G0127, G0247, and S0390. |
|